LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 52 filers reported holding LEAP THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,360 | -24.4% | 4,000,000 | 0.0% | 0.08% | -19.0% |
| Q4 2022 | $1,800 | -99.9% | 4,000,000 | 0.0% | 0.10% | -33.3% |
| Q3 2022 | $3,520,000 | -23.5% | 4,000,000 | 0.0% | 0.15% | -39.0% |
| Q2 2022 | $4,600,000 | -34.3% | 4,000,000 | 0.0% | 0.25% | -16.0% |
| Q1 2022 | $7,000,000 | -46.0% | 4,000,000 | 0.0% | 0.29% | -16.8% |
| Q4 2021 | $12,960,000 | -19.2% | 4,000,000 | 0.0% | 0.35% | -1.9% |
| Q3 2021 | $16,040,000 | +226.0% | 4,000,000 | +33.3% | 0.36% | +259.0% |
| Q2 2021 | $4,920,000 | -13.7% | 3,000,000 | 0.0% | 0.10% | -1.0% |
| Q1 2021 | $5,700,000 | -15.6% | 3,000,000 | 0.0% | 0.10% | -30.3% |
| Q4 2020 | $6,750,000 | +20.7% | 3,000,000 | +6.2% | 0.14% | +6.6% |
| Q3 2020 | $5,594,000 | -10.0% | 2,825,300 | -5.0% | 0.14% | -21.8% |
| Q2 2020 | $6,216,000 | +1473.7% | 2,974,000 | +1089.6% | 0.17% | +923.5% |
| Q1 2020 | $395,000 | – | 250,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 16,952,992 | $27,802,000 | 0.18% |
| Opaleye Management Inc. | 540,000 | $886,000 | 0.15% |
| ACT CAPITAL MANAGEMENT, LLC | 134,000 | $220,000 | 0.11% |
| Artal Group S.A. | 3,000,000 | $4,920,000 | 0.10% |
| HHLR ADVISORS, LTD. | 3,575,745 | $5,864,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 910,047 | $1,492,000 | 0.04% |
| PERSONAL CFO SOLUTIONS, LLC | 78,165 | $128,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 122,401 | $201,000 | 0.02% |
| Windsor Creek Advisors, LLC | 46,955 | $77,000 | 0.02% |
| Golden Green, Inc. | 14,824 | $24,000 | 0.02% |